Joris Guyon

Université de Bordeaux — France

Medicine · Health Sciences

12h-index661citations54works2.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(17), Cancer, Hypoxia, and Metabolism(12), Mitochondrial Function and Pathology(6), Cancer Cells and Metastasis(6), Cannabis and Cannabinoid Research(4)

Publications53 total

Clinical and toxicological epidemiology of intoxications by new psychoactive substances in Reunion Island
International Journal of Emergency Medicine·2025Open Access
Développement d’une méthode de dosage des antirétroviraux de longue durée d’action et application au suivi thérapeutique pharmacologique
Le Pharmacien Clinicien·2025
P01.04.B TRANSCRIPTOMICS OF PERIPHERAL AND CORE AREAS OF GLIOBLASTOMA REVEALS CNTN2 AS A POTENTIAL THERAPEUTIC TARGET
Neuro-Oncology·2025Open Access
Comparison of Two Strategies of Analysis of Urinary Protein Composition for the Diagnosis and Follow‐Up of Renal Diseases
Electrophoresis·2025
Development and Validation of a LC‐MS/MS Method for Ripretinib and Its Metabolite: Example of a Journey From Laboratory Bench to Routine Application With a Greenness Assessment
Biomedical Chromatography·2025· 1 citedOpen Access
Experimental protocols and models for assessing the permeation of antineoplastic drugs through gloves: From a scoping review to a guidelines proposition for future studies
Journal of Hazardous Materials·2025· 1 citedOpen Access
Development and validation of a LC-MS/MS method for ripretinib and its metabolite: example of a journey from laboratory bench to routine application with a greenness assessment
2025Open Access
Case series of severe intoxications associated with new psychoactive substances on Reunion Island: Clinical description and diagnostic challenges
Annales de Toxicologie Analytique·2025· 2 citedOpen Access
Psychoactive cocktail consumption on Reunion Island: a case report
Journal of Analytical Toxicology·2025· 2 cited
Exploiting metabolic vulnerability in glioblastoma using a brain-penetrant drug with a safe profile
EMBO Molecular Medicine·2025· 3 citedOpen Access
Paired transcriptomics of glioblastoma peripheral and core areas reveals CNTN2 as a potential therapeutic target
SSRN Electronic Journal·2025Open Access
Using DIMet for Differential Analysis of Labeled Metabolomics Data: A Step-by-step Guide Showcasing the Glioblastoma Metabolism
BIO-PROTOCOL·2024Open Access
Épidémie d’intoxication par de nouveaux opioïdes de synthèse sur l’île de la Réunion
Therapies·2024
DIMet: an open-source tool for differential analysis of targeted isotope-labeled metabolomics data
Bioinformatics·2024· 2 citedOpen Access
Datasets of the DIMet manuscript
Zenodo (CERN European Organization for Nuclear Research)·2024Open Access
Generation of glioblastoma in mice engrafted with human cytomegalovirus-infected astrocytes
Cancer Gene Therapy·2024· 32 citedOpen Access
Author Reply to Peer Reviews of Exploiting metabolic vulnerability in glioblastoma using a brain-penetrant drug with a safe profile
2024
SUMOylation controls Hu antigen R posttranscriptional activity in liver cancer
Cell Reports·2024· 4 citedOpen Access
Exploiting a metabolic vulnerability in brain tumour stem cells using a brain-penetrant drug with safe profile
2024Open Access
CNSC-15. MITOCHONDRIA TRANSFER VIA GLIOMA-ASTROCYTE NETWORK MICROTUBES REPROGRAMS TUMOR CELLS FOR ENHANCED TUMORIGENICITY
Neuro-Oncology·2023Open Access
page 1 of 3Next →

Frequent Co-authors

Thomas Daubon(36), Andréas Bikfalvi(20), Macha Nikolski(14), Benjamin Dartigues(12), Rolf Bjerkvig(9), Johanna Galvis(9), Hrvoje Miletić(8), Justine Rudewicz(8), Gro Vatne Røsland(7), Barbara Klink(7), Simon Storevik(6), Thomas Mathivet(6), Claire Larrieu(6), Audrey Burban(6), Mathiéu Molimard(6), Amélie Daveluy(6), Justin V. Joseph(5), Lars Ystaas(5), Capucine Magaut(5), Jubayer A. Hossain(5)